Centre to review DPCO & NPPP with Pharma and Medtech industry in upcoming meeting

New Delhi, May 3 (KNN) The central government is all set to meet the stakeholders from the pharma and medical device industry with the aim to review the working of Drug Pricing Control Order (DPCO), 2013 and National Pharmaceutical Pricing Policy, 2012 (NPPP), according to a report in the News18.

The meeting between the government and the industry representatives will likely be chaired by union health minister Mansukh Mandaviya in New Delhi on May 16.

As per reports, the drug price watchdog, National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers has been given the charge to hold the meeting, dubbed ‘workshop’, to answer industry concerns.

DPCO and NPPP are the rulebooks for the pharmaceutical and medical device industry which regulates the availability and pricing of medicines and medical devices in India.

“The department of pharmaceuticals as well as NPPA have been receiving various suggestions from the industry for amendments in DPCO as well as NPPP," the official said.

The meeting will be attended by S Aparna, secretary, Department of Pharmaceuticals (DoP), Kamlesh Kumar Pant, chairman of NPPA, Vinod Kotwal, member secretary of NPPA, and Awadesh Kumar Choudhury, economic adviser at DOP.  (KNN Bureau)